Status:
COMPLETED
Prophylactic Pregabalin to Decrease Pain During Medical Abortion
Lead Sponsor:
University of Hawaii
Collaborating Sponsors:
Society of Family Planning
Conditions:
Acute Pain
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Medical abortion has been associated with significant pain. The objective of this trial is to determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to the standard...
Eligibility Criteria
Inclusion
- Requested and consented for pregnancy termination by medical abortion
- Willing and able to complete multiple electronic surveys
Exclusion
- Previous participation in this trial
- Current use of pregabalin or gabapentin
- Contraindication to medical abortion with mifepristone and misoprostol
- Contraindication or allergy to ibuprofen, oxycodone, acetaminophen, or pregabalin
- Unable to understand and sign written informed consents in English
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT02782169
Start Date
June 1 2015
End Date
December 1 2016
Last Update
April 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Options Center
Honolulu, Hawaii, United States, 96826